Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma.
Cytomos has raised $6.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2024.
Cytomos's investors include British Business Bank, Scottish Enterprise, Archangels, Old College Capital.
Cytomos is headquartered in Edinburgh, United Kingdom.
Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma.
Cytomos is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cytomos — Funding & Investors." VCBacked, November 19, 2024, https://www.vcbacked.co/company/cytomos. Accessed September 29, 2026.
VCBacked. (2024). Cytomos — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/cytomos
{{cite web |title=Cytomos — Funding & Investors |url=https://www.vcbacked.co/company/cytomos |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated